BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ambit Biosciences 

Corporate Headquarters
4215 Sorrento Valley Boulevard
San Diego  California  92121  U.S.A.
Phone: 858-334-2100 Fax: 858-334-2199


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Medarex, Inc.  Co-development of Antibody therapeutics for targets discovered by Ambit





 Company News
Ambit Biosciences Announces Presentation Of Data From Clinical Investigations Of Quizartinib At The 19th Congress Of The European Hematology Association 6/12/2014 6:59:53 AM
Ambit Biosciences Announces Changes To Board Of Directors 6/4/2014 6:49:25 AM
Ambit Biosciences Announces Presentation Of Data From Clinical Investigations Of Quizartinib At The 2014 Annual Meeting Of The American Society of Clinical Oncology 6/4/2014 6:28:25 AM
Ambit Biosciences Announces Participation At Jefferies and Co. 2014 Global Healthcare Conference 5/28/2014 6:46:52 AM
Ambit Biosciences Announces First Quarter 2014 Operating Results 5/7/2014 6:38:37 AM
Ambit Biosciences Announces Participation At Deutsche Bank (DB) 39th Annual Healthcare Conference 5/1/2014 8:15:44 AM
Ambit Biosciences Announces Presentations Of Data From Clinical Investigations Of Quizartinib At The Annual Meeting Of The American Society of Clinical Oncology 4/23/2014 6:26:34 AM
Ambit Biosciences To Announce First Quarter 2014 Financial Results 4/22/2014 6:17:33 AM
Ambit Biosciences Initiation Of Quizartinib QUANTUM-R Phase 3 Trial 4/8/2014 9:06:42 AM
Ambit Biosciences Announces Initiation Of Phase 2 Cohort In MD Anderson Cancer Center Sponsored Study Of Quizartinib In AML And High Risk MDS 4/7/2014 10:01:29 AM
12345678910